Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 9

1.

ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model.

Heskamp S, van Laarhoven HW, Molkenboer-Kuenen JD, Franssen GM, Versleijen-Jonkers YM, Oyen WJ, van der Graaf WT, Boerman OC.

J Nucl Med. 2010 Oct;51(10):1565-72. doi: 10.2967/jnumed.110.075648. Epub 2010 Sep 16.

2.

Defining the pathway to insulin-like growth factor system targeting in cancer.

Rosenzweig SA, Atreya HS.

Biochem Pharmacol. 2010 Oct 15;80(8):1115-24. doi: 10.1016/j.bcp.2010.06.013. Epub 2010 Jun 23. Review.

3.

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507).

Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF, Frankel S, Peifer M, Thomas RK, Ladanyi M, Pao W.

PLoS One. 2009 Oct 6;4(10):e7273. doi: 10.1371/journal.pone.0007273.

4.

Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer.

Zha J, O'Brien C, Savage H, Huw LY, Zhong F, Berry L, Lewis Phillips GD, Luis E, Cavet G, Hu X, Amler LC, Lackner MR.

Mol Cancer Ther. 2009 Aug;8(8):2110-21. doi: 10.1158/1535-7163.MCT-09-0381. Epub 2009 Aug 11.

5.

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

Lerma E, Peiro G, Ramón T, Fernandez S, Martinez D, Pons C, Muñoz F, Sabate JM, Alonso C, Ojeda B, Prat J, Barnadas A.

Mod Pathol. 2007 Nov;20(11):1200-7. Epub 2007 Sep 21.

6.

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM.

Clin Cancer Res. 2007 Apr 15;13(8):2329-34.

7.

The IGF-I receptor in cell growth, transformation and apoptosis.

Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B.

Biochim Biophys Acta. 1997 Jun 7;1332(3):F105-26. No abstract available.

PMID:
9196021
8.

The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis.

Hernández-Sánchez C, Blakesley V, Kalebic T, Helman L, LeRoith D.

J Biol Chem. 1995 Dec 8;270(49):29176-81.

9.

The role of the insulin-like growth factor-I receptor in cancer.

LeRoith D, Werner H, Neuenschwander S, Kalebic T, Helman LJ.

Ann N Y Acad Sci. 1995 Sep 7;766:402-8. Review. No abstract available.

PMID:
7486685

Supplemental Content

Support Center